Technical Analysis for PTGX - Protagonist Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 9.11 3.29% 0.29
PTGX closed up 2.68 percent on Wednesday, February 19, 2020, on 44 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Mar 10
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up
Historical PTGX trend table...

Date Alert Name Type % Chg
Overbought Stochastic Strength 3.29%
180 Bullish Setup Bullish Swing Setup 6.05%
Overbought Stochastic Strength 6.05%
Overbought Stochastic Strength 9.10%
Overbought Stochastic Strength 6.05%
New Uptrend Bullish 9.23%
Overbought Stochastic Strength 9.23%
Upper Bollinger Band Walk Strength 8.71%
Overbought Stochastic Strength 8.71%
Upper Bollinger Band Touch Strength 8.71%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The Company's initial lead product candidates consists of PTG-100 and PTG-200, which have the potential to transform the existing treatment paradigm for inflammatory bowel disease, a GI disease consisting primarily of ulcerative colitis and Crohn's disease; PTG-300, an injectable hepcidin mimetic. Protagonist Therapeutics, Inc. is based in Milpitas, United States.
Medicine Biopharmaceutical Medical Specialties Immunology Autoimmune Diseases Inflammatory Bowel Disease Ulcerative Colitis Abdominal Pain Crohn's Disease Colitis Hepcidin

Is PTGX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 16.66
52 Week Low 4.47
Average Volume 207,781
200-Day Moving Average 10.62
50-Day Moving Average 7.48
20-Day Moving Average 7.98
10-Day Moving Average 8.43
Average True Range 0.40
ADX 29.38
+DI 25.43
-DI 10.25
Chandelier Exit (Long, 3 ATRs ) 7.65
Chandelier Exit (Short, 3 ATRs ) 8.30
Upper Bollinger Band 8.96
Lower Bollinger Band 7.00
Percent B (%b) 0.93
BandWidth 24.65
MACD Line 0.32
MACD Signal Line 0.23
MACD Histogram 0.0878
Fundamentals Value
Market Cap 149.07 Million
Num Shares 16.9 Million
EPS -3.23
Price-to-Earnings (P/E) Ratio -2.73
Price-to-Sales 0.00
Price-to-Book 4.14
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.32
Resistance 3 (R3) 9.27 9.05 9.23
Resistance 2 (R2) 9.05 8.93 9.08 9.20
Resistance 1 (R1) 8.94 8.85 9.00 8.99 9.18
Pivot Point 8.72 8.72 8.75 8.75 8.72
Support 1 (S1) 8.61 8.60 8.67 8.66 8.46
Support 2 (S2) 8.39 8.52 8.42 8.44
Support 3 (S3) 8.28 8.39 8.41
Support 4 (S4) 8.33